To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase

Volume: 55, Issue: 9, Pages: 1847 - 1854
Published: Sep 1, 2014
Abstract
Mounting ambiguity persists around the functional role of the plasma form of platelet-activating factor acetylhydrolase (PAF-AH). Because PAF-AH hydrolyzes PAF and related oxidized phospholipids, it is widely accepted as an anti-inflammatory enzyme. On the other hand, its actions can also generate lysophosphatidylcholine (lysoPC), a component of bioactive atherogenic oxidized LDL, thus allowing the enzyme to have proinflammatory capabilities....
Paper Details
Title
To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase
Published Date
Sep 1, 2014
Volume
55
Issue
9
Pages
1847 - 1854
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.